REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,478,000 | -1.0% | 94,433 | -13.0% | 0.56% | -28.3% |
Q1 2020 | $3,513,000 | -3.6% | 108,483 | +21.9% | 0.78% | +30.4% |
Q4 2019 | $3,645,000 | -13.3% | 88,964 | -24.6% | 0.60% | -16.3% |
Q3 2019 | $4,203,000 | -24.5% | 118,055 | +8.9% | 0.71% | -17.3% |
Q2 2019 | $5,569,000 | -26.0% | 108,418 | -17.4% | 0.86% | -26.2% |
Q1 2019 | $7,522,000 | +179.0% | 131,258 | +104.2% | 1.17% | +118.1% |
Q4 2018 | $2,696,000 | -62.2% | 64,265 | -32.0% | 0.54% | -40.6% |
Q3 2018 | $7,134,000 | -14.9% | 94,492 | -19.1% | 0.90% | -21.9% |
Q2 2018 | $8,381,000 | – | 116,813 | – | 1.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |